Company Info for bgi.com | IcebreakerMembers
Frank is the cofounder and builder of Open Biobank.
Biobank is the most critical infrastructure for the welfare of both human being and animals. But in current centralized biobank(eg, UK BIOBANK(500,000 people)) scenario, individual can not own the data, vote for the data usage, and get the benefit from data.
We propose Open Biobank —Omics-sequencing based decentralized bio data infrastructure and protocol. We are dedicated to serving a more diverse population, addressing the existing racial bias in UK Biobank samples. Ensuring that omics data remains open and accessible while protecting user privacy, unaffected by geopolitical factors. Upholding the spirit of web3 - of the people, by the people, for the people.
Open Biobank will build the largest Open Biobank (1 million omics node, 10 million people's health data) for all creatures . 
As an experienced angel investor, venture capitalist, and strategic advisor, I specialize in identifying and supporting high-potential startups across the life sciences, biotech, and healthcare sectors. With over 18 years of hands-on experience in the biotech ecosystem, I focus on early-stage companies transforming diagnostics, therapeutics, genomics, medical technology, and digital health.
I have built a global investment portfolio in biotech, life sciences, and health innovation, backing pioneering companies that are reshaping patient outcomes, unlocking novel therapies, and accelerating personalized medicine. From synthetic biology and immunotherapy to AI in healthcare and lab automation, I’ve worked closely with founders solving hard problems at the intersection of biology and technology.
My experience spans strategic roles at leading global institutions like AbbVie, Pfizer, BGI Genomics, GRAIL, and The Francis Crick Institute, where I led international operations, global strategy, and business development across biotech and health sectors. I currently serve as Chief Business Officer at The King's Fund, helping shape the future of healthcare innovation and policy.
Alongside investing, I mentor disruptive startups through platforms like FasterCapital, GV (Google Ventures), and Lindus Health. I bring hands-on guidance in biotech fundraising, regulatory strategy, clinical trial acceleration, product-market fit, and commercial scaling in the healthtech and medtech sectors.
I actively invest in companies like BillionToOne, AliveCor, eGenesis, Quartzy, TG Therapeutics, InstantDoctor, Rapport Therapeutics, and Forbion—advancing genomics, non-invasive diagnostics, and accessible therapeutics. As a biotech and life sciences investor, I look for bold science, responsible innovation, and scalable solutions to improve global health. 
